
# Fine-tuning Vision Language Models with Graph-based Knowledge for Explainable Medical Image Analysis

**Korean Title:** ê·¸ë˜í”„ ê¸°ë°˜ ì§€ì‹ì„ í™œìš©í•œ ì‹œê° ì–¸ì–´ ëª¨ë¸ì˜ ë¯¸ì„¸ ì¡°ì •: ì„¤ëª… ê°€ëŠ¥í•œ ì˜ë£Œ ì˜ìƒ ë¶„ì„

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily/2025-09-19|2025-09-19]] [[categories/cs.AI|cs.AI]]

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸš€ Evolved Concepts**: Explainable Medical Image Analysis

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[Intelligent Healthcare Imaging Platform An VLM-Based Framework for Automated Medical Image Analysis and Clinical Report Generation]] (82.8% similar)
- [[Locally_Explaining_Prediction_Behavior_via_Gradual_Interventions_and_Measuring_Property_Gradients_20250918|Locally Explaining Prediction Behavior via Gradual Interventions and Measuring Property Gradients]] (81.4% similar)
- [[Generative_AI_for_Misalignment-Resistant_Virtual_Staining_to_Accelerate_Histopathology_Workflows_20250918|Generative AI for Misalignment-Resistant Virtual Staining to Accelerate Histopathology Workflows]] (81.1% similar)
- [[Taylor-Series_Expanded_Kolmogorov-Arnold_Network_for_Medical_Imaging_Classification_20250918|Taylor-Series Expanded Kolmogorov-Arnold Network for Medical Imaging Classification]] (80.4% similar)
- [[Semi-MoE Mixture-of-Experts meets Semi-Supervised Histopathology Segmentation]] (80.1% similar)

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2503.09808v2 Announce Type: replace-cross 
Abstract: Accurate staging of Diabetic Retinopathy (DR) is essential for guiding timely interventions and preventing vision loss. However, current staging models are hardly interpretable, and most public datasets contain no clinical reasoning or interpretation beyond image-level labels. In this paper, we present a novel method that integrates graph representation learning with vision-language models (VLMs) to deliver explainable DR diagnosis. Our approach leverages optical coherence tomography angiography (OCTA) images by constructing biologically informed graphs that encode key retinal vascular features such as vessel morphology and spatial connectivity. A graph neural network (GNN) then performs DR staging while integrated gradients highlight critical nodes and edges and their individual features that drive the classification decisions. We collect this graph-based knowledge which attributes the model's prediction to physiological structures and their characteristics. We then transform it into textual descriptions for VLMs. We perform instruction-tuning with these textual descriptions and the corresponding image to train a student VLM. This final agent can classify the disease and explain its decision in a human interpretable way solely based on a single image input. Experimental evaluations on both proprietary and public datasets demonstrate that our method not only improves classification accuracy but also offers more clinically interpretable results. An expert study further demonstrates that our method provides more accurate diagnostic explanations and paves the way for precise localization of pathologies in OCTA images.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

arXiv:2503.09808v2 ë°œí‘œ ìœ í˜•: êµì°¨ êµì²´  
ì´ˆë¡: ë‹¹ë‡¨ë³‘ì„± ë§ë§‰ë³‘ì¦(DR)ì˜ ì •í™•í•œ ë‹¨ê³„ êµ¬ë¶„ì€ ì ì‹œ ê°œì…ì„ ìœ ë„í•˜ê³  ì‹œë ¥ ì†ì‹¤ì„ ì˜ˆë°©í•˜ê¸° ìœ„í•´ í•„ìˆ˜ì ì…ë‹ˆë‹¤. ê·¸ëŸ¬ë‚˜ í˜„ì¬ì˜ ë‹¨ê³„ êµ¬ë¶„ ëª¨ë¸ì€ í•´ì„í•˜ê¸° ì–´ë ¤ìš°ë©°, ëŒ€ë¶€ë¶„ì˜ ê³µê°œ ë°ì´í„°ì…‹ì€ ì´ë¯¸ì§€ ìˆ˜ì¤€ì˜ ë ˆì´ë¸” ì™¸ì— ì„ìƒì  ì¶”ë¡ ì´ë‚˜ í•´ì„ì„ í¬í•¨í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ë³¸ ë…¼ë¬¸ì—ì„œëŠ” ê·¸ë˜í”„ í‘œí˜„ í•™ìŠµê³¼ ë¹„ì „-ì–¸ì–´ ëª¨ë¸(VLMs)ì„ í†µí•©í•˜ì—¬ ì„¤ëª… ê°€ëŠ¥í•œ DR ì§„ë‹¨ì„ ì œê³µí•˜ëŠ” ìƒˆë¡œìš´ ë°©ë²•ì„ ì œì‹œí•©ë‹ˆë‹¤. ìš°ë¦¬ì˜ ì ‘ê·¼ë²•ì€ ìƒë¬¼í•™ì ìœ¼ë¡œ ì •ë³´ê°€ í¬í•¨ëœ ê·¸ë˜í”„ë¥¼ êµ¬ì„±í•˜ì—¬ í˜ˆê´€ í˜•íƒœ ë° ê³µê°„ ì—°ê²°ì„±ê³¼ ê°™ì€ ì£¼ìš” ë§ë§‰ í˜ˆê´€ íŠ¹ì§•ì„ ì¸ì½”ë”©í•¨ìœ¼ë¡œì¨ ê´‘í•™ ì½”íˆì–´ëŸ°ìŠ¤ ë‹¨ì¸µì´¬ì˜ í˜ˆê´€ì¡°ì˜ìˆ (OCTA) ì´ë¯¸ì§€ë¥¼ í™œìš©í•©ë‹ˆë‹¤. ê·¸ë˜í”„ ì‹ ê²½ë§(GNN)ì€ DR ë‹¨ê³„ êµ¬ë¶„ì„ ìˆ˜í–‰í•˜ë©°, í†µí•© ê¸°ìš¸ê¸°ëŠ” ë¶„ë¥˜ ê²°ì •ì— ì˜í–¥ì„ ë¯¸ì¹˜ëŠ” ì¤‘ìš”í•œ ë…¸ë“œì™€ ì—£ì§€ ë° ê·¸ ê°œë³„ íŠ¹ì§•ì„ ê°•ì¡°í•©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ëª¨ë¸ì˜ ì˜ˆì¸¡ì„ ìƒë¦¬í•™ì  êµ¬ì¡°ì™€ ê·¸ íŠ¹ì„±ì— ê·€ì†ì‹œí‚¤ëŠ” ì´ ê·¸ë˜í”„ ê¸°ë°˜ ì§€ì‹ì„ ìˆ˜ì§‘í•©ë‹ˆë‹¤. ê·¸ëŸ° ë‹¤ìŒ ì´ë¥¼ VLMsë¥¼ ìœ„í•œ í…ìŠ¤íŠ¸ ì„¤ëª…ìœ¼ë¡œ ë³€í™˜í•©ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ì´ëŸ¬í•œ í…ìŠ¤íŠ¸ ì„¤ëª…ê³¼ í•´ë‹¹ ì´ë¯¸ì§€ë¥¼ ì‚¬ìš©í•˜ì—¬ í•™ìƒ VLMì„ í›ˆë ¨ì‹œí‚¤ê¸° ìœ„í•´ ì§€ì‹œ ì¡°ì •ì„ ìˆ˜í–‰í•©ë‹ˆë‹¤. ì´ ìµœì¢… ì—ì´ì „íŠ¸ëŠ” ë‹¨ì¼ ì´ë¯¸ì§€ ì…ë ¥ë§Œìœ¼ë¡œ ì§ˆë³‘ì„ ë¶„ë¥˜í•˜ê³  ì¸ê°„ì´ í•´ì„í•  ìˆ˜ ìˆëŠ” ë°©ì‹ìœ¼ë¡œ ê·¸ ê²°ì •ì„ ì„¤ëª…í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë…ì  ë° ê³µê°œ ë°ì´í„°ì…‹ì— ëŒ€í•œ ì‹¤í—˜ì  í‰ê°€ ê²°ê³¼, ìš°ë¦¬ì˜ ë°©ë²•ì´ ë¶„ë¥˜ ì •í™•ë„ë¥¼ í–¥ìƒì‹œí‚¬ ë¿ë§Œ ì•„ë‹ˆë¼ ì„ìƒì ìœ¼ë¡œ ë” í•´ì„ ê°€ëŠ¥í•œ ê²°ê³¼ë¥¼ ì œê³µí•¨ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. ì „ë¬¸ê°€ ì—°êµ¬ëŠ” ë˜í•œ ìš°ë¦¬ì˜ ë°©ë²•ì´ ë” ì •í™•í•œ ì§„ë‹¨ ì„¤ëª…ì„ ì œê³µí•˜ê³  OCTA ì´ë¯¸ì§€ì—ì„œ ë³‘ë¦¬ì˜ ì •í™•í•œ ìœ„ì¹˜ë¥¼ ì§€ì •í•  ìˆ˜ ìˆëŠ” ê¸¸ì„ ì—´ì–´ì¤€ë‹¤ëŠ” ê²ƒì„ ë³´ì—¬ì¤ë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ë‹¹ë‡¨ë§ë§‰ë³‘ì¦(DR)ì˜ ì •í™•í•œ ë‹¨ê³„ êµ¬ë¶„ì„ ìœ„í•´ ê·¸ë˜í”„ í‘œí˜„ í•™ìŠµê³¼ ì‹œê°-ì–¸ì–´ ëª¨ë¸(VLM)ì„ í†µí•©í•œ ìƒˆë¡œìš´ ë°©ë²•ì„ ì œì•ˆí•©ë‹ˆë‹¤. ì´ ë°©ë²•ì€ ê´‘í•™ ì½”íˆì–´ëŸ°ìŠ¤ ë‹¨ì¸µ ì´¬ì˜ í˜ˆê´€ì¡°ì˜ìˆ (OCTA) ì´ë¯¸ì§€ë¥¼ í™œìš©í•˜ì—¬ í˜ˆê´€ í˜•íƒœì™€ ê³µê°„ì  ì—°ê²°ì„±ì„ í¬í•¨í•œ ë§ë§‰ í˜ˆê´€ì˜ ì£¼ìš” íŠ¹ì§•ì„ ê·¸ë˜í”„ë¡œ í‘œí˜„í•©ë‹ˆë‹¤. ê·¸ë˜í”„ ì‹ ê²½ë§(GNN)ì„ í†µí•´ DR ë‹¨ê³„ë¥¼ êµ¬ë¶„í•˜ë©°, í†µí•© ê¸°ìš¸ê¸° ê¸°ë²•ìœ¼ë¡œ ë¶„ë¥˜ ê²°ì •ì— ì¤‘ìš”í•œ ë…¸ë“œì™€ ì—£ì§€ë¥¼ ê°•ì¡°í•©ë‹ˆë‹¤. ì´ëŸ¬í•œ ê·¸ë˜í”„ ê¸°ë°˜ ì§€ì‹ì„ í…ìŠ¤íŠ¸ë¡œ ë³€í™˜í•˜ì—¬ VLMì„ í›ˆë ¨í•˜ê³ , ìµœì¢… ëª¨ë¸ì€ ë‹¨ì¼ ì´ë¯¸ì§€ ì…ë ¥ë§Œìœ¼ë¡œ ì§ˆë³‘ì„ ë¶„ë¥˜í•˜ê³  ì„¤ëª…í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì‹¤í—˜ ê²°ê³¼, ì´ ë°©ë²•ì€ ë¶„ë¥˜ ì •í™•ë„ë¥¼ ë†’ì´ê³  ì„ìƒì ìœ¼ë¡œ í•´ì„ ê°€ëŠ¥í•œ ê²°ê³¼ë¥¼ ì œê³µí•©ë‹ˆë‹¤. ì „ë¬¸ê°€ ì—°êµ¬ì—ì„œëŠ” ì´ ë°©ë²•ì´ ë” ì •í™•í•œ ì§„ë‹¨ ì„¤ëª…ì„ ì œê³µí•˜ê³  OCTA ì´ë¯¸ì§€ì—ì„œ ë³‘ë³€ì˜ ì •í™•í•œ ìœ„ì¹˜ë¥¼ íŒŒì•…í•˜ëŠ” ë° ë„ì›€ì„ ì¤€ë‹¤ê³  í‰ê°€ë˜ì—ˆìŠµë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ë‹¹ë‡¨ë§ë§‰ë³‘ì¦(DR)ì˜ ì •í™•í•œ ë‹¨ê³„ êµ¬ë¶„ì„ ìœ„í•´ ê·¸ë˜í”„ í‘œí˜„ í•™ìŠµê³¼ ì‹œê°-ì–¸ì–´ ëª¨ë¸(VLM)ì„ í†µí•©í•œ ìƒˆë¡œìš´ ë°©ë²•ì„ ì œì•ˆí•©ë‹ˆë‹¤.

- 2. ìƒë¬¼í•™ì  ì •ë³´ë¥¼ ë°˜ì˜í•œ ê·¸ë˜í”„ë¥¼ í†µí•´ ë§ë§‰ í˜ˆê´€ì˜ í˜•íƒœì™€ ê³µê°„ì  ì—°ê²°ì„±ì„ ì¸ì½”ë”©í•˜ì—¬ DR ë‹¨ê³„ë¥¼ ë¶„ë¥˜í•©ë‹ˆë‹¤.

- 3. ê·¸ë˜í”„ ì‹ ê²½ë§(GNN)ì„ ì‚¬ìš©í•˜ì—¬ DR ë‹¨ê³„ë¥¼ ë¶„ë¥˜í•˜ê³ , í†µí•© ê¸°ìš¸ê¸°ë¥¼ í†µí•´ ì¤‘ìš”í•œ ë…¸ë“œì™€ ì—£ì§€ë¥¼ ê°•ì¡°í•˜ì—¬ ë¶„ë¥˜ ê²°ì •ì— ê¸°ì—¬í•˜ëŠ” íŠ¹ì§•ì„ ì„¤ëª…í•©ë‹ˆë‹¤.

- 4. ì‹¤í—˜ ê²°ê³¼, ì œì•ˆëœ ë°©ë²•ì€ ë¶„ë¥˜ ì •í™•ë„ë¥¼ í–¥ìƒì‹œí‚¤ê³ , ì„ìƒì ìœ¼ë¡œ í•´ì„ ê°€ëŠ¥í•œ ê²°ê³¼ë¥¼ ì œê³µí•©ë‹ˆë‹¤.

- 5. ì „ë¬¸ê°€ ì—°êµ¬ë¥¼ í†µí•´ ì œì•ˆëœ ë°©ë²•ì´ ë” ì •í™•í•œ ì§„ë‹¨ ì„¤ëª…ì„ ì œê³µí•˜ë©°, OCTA ì´ë¯¸ì§€ì—ì„œ ë³‘ë³€ì˜ ì •í™•í•œ ìœ„ì¹˜ íŒŒì•…ì— ê¸°ì—¬í•¨ì„ ì…ì¦í–ˆìŠµë‹ˆë‹¤.

---

*Generated on 2025-09-19 15:12:49*